{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:14Z","timestamp":1789990874491,"version":"4.0.1"},"reference-count":211,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.jneuroim.2008.12.008","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T04:48:23Z","timestamp":1233031703000},"page":"3-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Interferon alpha and neuromuscular disorders"],"prefix":"10.1016","volume":"207","author":[{"given":"Joerg-Patrick","family":"St\u00fcbgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.12.008_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2169\/internalmedicine.40.1109","article-title":"Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection","volume":"40","author":"Aisa","year":"2001","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0248-8663(00)89230-9","article-title":"Association between polymyositis and hepatitis C infection. Treatment-related difficulties","volume":"21","author":"Alric","year":"2000","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.20184","article-title":"Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study","volume":"31","author":"Ammendola","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1097-0142(19950815)76:4<678::AID-CNCR2820760422>3.0.CO;2-Q","article-title":"Acute rhabdomyolysis after concurrent administration of interleukin-2, IFN, and chemotherapy for metastatic melanoma","volume":"76","author":"Anderlini","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jnr.490190304","article-title":"Rat interferon enhances the expression of acetylcholine receptors in rat myotubes in culture","volume":"19","author":"Andr\u00e9","year":"1988","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.60.6.661","article-title":"Peripheral neuropathy associated with essential cryoglobulinemia: a role for hepatitis C virus infection?","volume":"60","author":"Apartis","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(95)90490-5","article-title":"Symptomatic myopathy associated with interferon treatment for chronic hepatitis C","volume":"345","author":"Arai","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/eji.1830130602","article-title":"Interferon as macrophage-activating factors II. Enhanced secretion of interleukin-I by lipopolysaccharide-stimulated human monocytes","volume":"13","author":"Arenzana-Seisdedoes","year":"1983","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.410340524","article-title":"High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy","volume":"34","author":"Authier","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1212\/01.WNL.0000044399.71601.EA","article-title":"Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy","volume":"60","author":"Authier","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib11","first-page":"357","article-title":"Guillain\u2013Barr\u00e9 syndrome: etiology and pathogenesis","volume":"54","author":"Avila-Funes","year":"2002","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinemia-related vasculitis following treatment of hepatitis C with peginterferon alfa","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.45.2.382","article-title":"Myasthenia gravis during interferon alfa therapy","volume":"45","author":"Batocchi","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib15","first-page":"111","article-title":"Oculomotor nerve paralysis induced by alpha II-interferon","volume":"90","author":"Bauherz","year":"1990","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000109410","article-title":"Development of myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin","volume":"75","author":"Bektas","year":"2007","journal-title":"Digestion"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(85)90999-7","article-title":"Neuralgic amyotrophy and polyneuroathy during interferon therapy","volume":"1","author":"Bernsen","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.1988.00520280099024","article-title":"Bilateral amyotrophy induced by interferon treatment","volume":"45","author":"Bernsen","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10067-005-1093-x","article-title":"Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: a case report and review of the literature","volume":"24","author":"Beuthien","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0006-291X(81)91284-5","article-title":"Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity","volume":"101","author":"Blalock","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/jnnp.62.3.302-a","article-title":"Low dose interferon-alpha is safe in patients with myasthenia gravis","volume":"62","author":"Bolay","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-5728(97)00146-X","article-title":"Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity","volume":"82","author":"Bolay","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-5728(96)00191-9","article-title":"T-cell-mediated epineural vasculitis and humeral-mediated microangiopathy in cryoglobulinemic neuropathy","volume":"73","author":"Bonetti","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000112905","article-title":"Myasthenia gravis following IFN-alpha-2a treatment","volume":"38","author":"Bora","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/10799900152434321","article-title":"Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C","volume":"21","author":"Borgia","year":"2001","journal-title":"J. interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/294768a0","article-title":"Evidence that types I and II interferons have different receptors","volume":"294","author":"Branca","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/01.wnl.0000233889.07772.76","article-title":"Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV","volume":"67","author":"Briani","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.6154315","article-title":"Inhibition of cell motility by interferon","volume":"208","author":"Brouty-Boye","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","article-title":"Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients","volume":"28","author":"Buskila","year":"1998","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"Pegylated interferon alpha-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1017\/S0022215100142197","article-title":"Sudden hearing loss in a patient hepatitis C (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis","volume":"112","author":"Cadoni","year":"1998","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/278558a0","article-title":"Interferon enhances the excitability of cultured neurons","volume":"278","author":"Calvet","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.20517","article-title":"Lewis\u2013Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems","volume":"34","author":"Caporale","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2004.06144.x","article-title":"Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis","volume":"151","author":"Caproni","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib37","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","article-title":"Long-term results of therapy with interferon-\u03b1 for type II essential mixed cryoglobulinemia","volume":"78","author":"Casato","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib38","first-page":"863","article-title":"Thyrotoxic hypokalemic periodic paralysis as the first manifestation of interferon-[alpha]-induced Graves disease","volume":"40","author":"Cesur","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.32.7.725","article-title":"The pathogenesis of cryoglobulinemic neuropathy","volume":"32","author":"Chad","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.157.2.522","article-title":"IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2","volume":"157","author":"Chakrabarti","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib41","first-page":"244","article-title":"Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis","volume":"88","author":"Chung","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002960050103","article-title":"Polymyositis occurring during \u03b1-interferon treatment for malignant melanoma: a case report and review of the literature","volume":"19","author":"Cirigliano","year":"1999","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08916930310001602137","article-title":"Potential mechanisms of interferon-alpha induced autoimmunity","volume":"36","author":"Conrad","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.1997.269-ce1161.x","article-title":"Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans","volume":"107","author":"Corssmit","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999000750053690","article-title":"Biologic responses to IFN-alpha administration in humans","volume":"20","author":"Corssmit","year":"2000","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1529-8027.2006.00108.x","article-title":"Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha","volume":"11","author":"Couto","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib47","first-page":"485","article-title":"Peripheral neuropathy during treatment with alpha-2 interferon","volume":"75","author":"Cudillo","year":"1990","journal-title":"Hematologica"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(85)80002-3","article-title":"Does the immune system communicate with the central nervous system? Interferon modifies central nervous activity","volume":"9","author":"Dafny","year":"1985","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib49","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1596::AID-MUS9>3.0.CO;2-5","article-title":"Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C","volume":"19","author":"David","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib50","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.4049\/jimmunol.157.12.5675","article-title":"IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis","volume":"157","author":"Deng","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","article-title":"Dermatomyositis after interferon alpha treatment","volume":"17","author":"Dietrich","year":"2000","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib52","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archderm.134.7.880","article-title":"Myopathic syndrome associated with long-term recombinant interferon alfa treatment in 4 patients with skin disorders","volume":"134","author":"Dippel","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib53","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/ard.2005.051086","article-title":"Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis","volume":"65","author":"Dorph","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.510260720","article-title":"Side effects of alpha interferon in chronic hepatitis C","volume":"26","author":"Dusheiko","year":"1997","journal-title":"Hepatology Suppl."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib55","series-title":"The Cytokine Handbook","first-page":"1233","article-title":"Interferon \u03b1: biology, pharmacology and therapy for chronic viral hepatitis","author":"Dusheiko","year":"2003"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0168-8278(96)80225-X","article-title":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study","volume":"25","author":"Dusheiko","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1023\/A:1026683007277","article-title":"Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection","volume":"44","author":"Eddy","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/088800199276868","article-title":"Peripheral neuropathy during alpha-interferon therapy in a child with Hodgkin's disease","volume":"16","author":"Emir","year":"1999","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunnolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Human Pathol."},{"issue":"Supplement 3","key":"10.1016\/j.jneuroim.2008.12.008_bib60","first-page":"467","article-title":"Long-term interferon alpha-2A (I\u03b1) benefits otherwise-intractable chronic fever-responsive Schwannian immune neuropathy (FR-SIN)","volume":"42","author":"Engel","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib61","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.10140","volume":"46","author":"Englund","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0115426505020004369","article-title":"The cancer cachexia syndrome: a review of metabolic and clinical manifestations","volume":"20","author":"Esper","year":"2005","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib63","first-page":"1329","article-title":"Symptomatic myopathy during interferon alfa therapy for chronic myelogenous leukemia","volume":"12","author":"Falcone","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0167-5699(00)01710-2","article-title":"Type I interferons and T helper development","volume":"21","author":"Farrar","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib66","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2362.1993.tb00782.x","article-title":"Hepatitis C virus and mixed cryoglobulinema","volume":"23","author":"Ferri","year":"1993","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib68","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib69","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemai","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib70","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","article-title":"Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection","volume":"39","author":"Ferri","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib71","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1023\/A:1026691416498","article-title":"Fatal exacerbation of hepatitis C related cryoglobulinemia with interferon alpha therapy","volume":"44","author":"Friedman","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2169\/internalmedicine.33.637","article-title":"Abducens nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C","volume":"33","author":"Fukumoto","year":"1994","journal-title":"Intern Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib73","first-page":"940","article-title":"Acute reversible rhabdomyolysis during interferon alpha2b therapy for hepatitis C","volume":"98","author":"Gabrielli","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib74","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1988.00520350048015","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia","volume":"45","author":"Garcia-Bragado","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9343(89)80498-X","article-title":"Severe neuropathy associated with low-dose recombinant interferon-alpha","volume":"87","author":"Gastineau","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jnnp.55.2.116","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia","volume":"55","author":"Gemignani","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib77","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/rheumatology\/37.12.1349","article-title":"Hypothyroid myopathy as a complication of interferon alpha therapy for chronic active hepatitis C virus infection","volume":"37","author":"Ghilardi","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib78","first-page":"369","article-title":"Peripheral neuropathy in type II essential cryoglobulinemia: \u03b1-IFN versus deflazacort therapy","volume":"13","author":"Ghini","year":"1994","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2893.2003.00478.x","article-title":"Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C","volume":"11","author":"Golstein","year":"2004","journal-title":"J. Viral. Hepatitis"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib80","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.48.3.777","article-title":"Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.50.1.84","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a","volume":"50","author":"Gorson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib82","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.48.4.855","article-title":"Peripheral neuropathy associated with sicca complex","volume":"48","author":"Grant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib83","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","article-title":"Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications","volume":"69","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib84","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib85","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sj\u00f8gren's syndrome","volume":"27","author":"Griffen","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib86","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9343(02)01102-6","article-title":"Anterior ischemic optic neuropathy caused by interferon alpha therapy","volume":"112","author":"Gupta","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib87","first-page":"75","article-title":"Development of myasthenia gravis after interferon alpha therapy","volume":"39","author":"Gurtubay","year":"1999","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib88","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics: lessons from interferon \u03b1","volume":"91","author":"Gutterman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib89","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-\u03b1 associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2893.1996.tb00106.x","article-title":"Myasthenia gravis and hepatitis C virus infection","volume":"3","author":"Halfon","year":"1996","journal-title":"J. Viral. Hepatitis."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib91","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<295::AID-MUS26>3.0.CO;2-C","article-title":"Clinical improvement following interferon-\u03b1 alone as an initial treatment in CIDP","volume":"23","author":"Harada","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1995.03530020044018","article-title":"Dramatic worsening of hepatitis C virus related cryoglobulinemia subsequent to treatment with interferon alpha","volume":"274","author":"Harle","year":"1995","journal-title":"J.A.M.A."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2133.2001.03995.x","article-title":"Repeatable acute rhabdomyolysis with multiple organ dysfunction because of interferon \u03b1 and dacarbazine treatment in metastatic melanoma","volume":"144","author":"Hauschild","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib94","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1212\/WNL.54.11.2186","article-title":"Myositis during long-term interferon-\u03b1 treatment","volume":"54","author":"Hengstman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib95","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jir.2005.25.174","article-title":"Bell's palsy associated with IFN-alpha and ribavirin therapy for chronic hepatitis C virus infection","volume":"25","author":"Hoare","year":"2005","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/jir.1997.17.263","article-title":"Interferons suppress mitochondrial gene transcription by depleting mitochondrial transcription factor A (mt TFA)","volume":"17","author":"Inagaki","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib97","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E","article-title":"Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy","volume":"43","author":"Ioannou","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib98","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jnnp.70.3.408","article-title":"Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C","volume":"70","author":"Irioka","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib99","first-page":"221","article-title":"Peripheral neuropathy during interferon alpha therapy","volume":"20","author":"Jaubert","year":"1991","journal-title":"Presse Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib100","first-page":"147","article-title":"Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis","volume":"26","author":"John","year":"2007","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib101","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/qjmed\/91.6.393","article-title":"Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon","volume":"91","author":"Kalkner","year":"1998","journal-title":"Q. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0140-6736(90)91768-6","article-title":"Suppression of hepatitis C virus RNA by interferon-alpha","volume":"36","author":"Kanai","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib103","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(94)90237-2","article-title":"Sudden hearing loss associated with interferon","volume":"343","author":"Kanda","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/00206099509071903","article-title":"Interferon-\u03b1 induced sudden hearing loss","volume":"34","author":"Kanda","year":"1995","journal-title":"Audiology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mus.880130703","article-title":"Peripheral neuropathy in Sjogren's syndrome","volume":"13","author":"Kaplan","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib106","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s000180050248","article-title":"The structure of human interferon-\u03b2: implications for activity","volume":"54","author":"Karpusas","year":"1998","journal-title":"CMLS Cell Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib107","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.45.3.407","article-title":"Hepatitis C infection, cryoglobuliemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review","volume":"45","author":"Khella","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib108","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3748\/wjg.14.318","article-title":"Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon\u03b1-2a therapy for chronic hepatitis virus infection","volume":"14","author":"Khiani","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib110","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1200\/JCO.2002.03.052","article-title":"Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy","volume":"20","author":"Kirkwood","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib111","first-page":"980","article-title":"A case of myasthenia gravis which developed myasthenic crises after alpha-interferon therapy for chronic hepatitis C","volume":"36","author":"Konishi","year":"1996","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib112","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1478-3231.2006.01436.x","article-title":"Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-\u03b12b and ribavirin: clinical, laboratory and neurophysiological study","volume":"27","author":"Koskinas","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib113","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(03)00390-5","article-title":"Autoimmune aspects of cytokine and anticytokine therapies","volume":"115","author":"Krause","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJM199801153380316","article-title":"Bone marrow necrosis and the Lambert\u2013Eaton syndrome associated with interferon alfa treatment","volume":"338","author":"Kumakara","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib115","first-page":"1641","article-title":"Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection","volume":"23","author":"La Civita","year":"1996","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib116","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/ajpcell.00120.2007","article-title":"IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium","volume":"294","author":"Lechner","year":"2008","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib117","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3346\/jkms.2002.17.1.141","article-title":"A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B","volume":"17","author":"Lee","year":"2002","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib118","first-page":"A 380","article-title":"A randomized trial comparing alpha-interferon and intravenous immunoglobulin in polyneuropathy associated with IgM monoclonal gammopathy","volume":"46","author":"Leger","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib119","first-page":"927","article-title":"Myasthenia gravis after interferon-alpha treatment","volume":"19","author":"Lensch","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199401000-00005","article-title":"Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature","volume":"73","author":"Levey","year":"1994","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib121","first-page":"605","article-title":"MHC class I overexpression on muscles in early juvenile dermatomyositis","volume":"31","author":"Li","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib122","first-page":"403","article-title":"Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment","volume":"23","author":"Lidove","year":"1999","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib123","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"Lopez de Padilla","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib124","first-page":"1048","article-title":"Mononeuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C","volume":"35","author":"Maeda","year":"1995","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib125","series-title":"The Immune Response. Basic and Clinical Principles","first-page":"469","author":"Mak","year":"2006"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib127","first-page":"869","article-title":"Interferon \u03b1-2a therapy and pregnancy. Report of a case of chronic inflammatory demyelinating polyneuropathy","volume":"77","author":"Mancuso","year":"1998","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/mus.20487","article-title":"Trigeminal neuropathy related to interferon-alpha treatment","volume":"33","author":"Marey-Lopez","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.63.1.28","article-title":"A randomized clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study group","volume":"63","author":"Mariette","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.69.2.279","article-title":"A randomized double blind trial versus placebo does not confirm the benefit of -interferon in polyneuropathy associated with monoclonal IgM","volume":"69","author":"Mariette","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.65.4.604","article-title":"Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha","volume":"65","author":"Marzo","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib132","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.60.3.348-a","article-title":"Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis","volume":"60","author":"Mase","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib133","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2169\/internalmedicine.33.806","article-title":"The first case of polymyositis associated with interferon therapy","volume":"33","author":"Matsuya","year":"1994","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/WNL.39.3.390","article-title":"Peripheral neuropathy in primary Sj\u00f8gren's syndrome","volume":"39","author":"Mellgren","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib135","first-page":"805","article-title":"Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia","volume":"22","author":"Melstrom","year":"2007","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib136","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<433::AID-MUS17>3.0.CO;2-O","article-title":"Chronic inflammatory demyelinating poluneuropathy after treatment with interferon-alpha","volume":"23","author":"Meriggioli","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib137","first-page":"1142","article-title":"Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules in human myotubes","volume":"143","author":"Michaelis","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib138","first-page":"175","article-title":"Interferon in the treatment of mixed cryoglobulinemia","volume":"Suppl.13","author":"Migliaresi","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib139","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","article-title":"Approaches for identifying and defining environmentally associated rheumatic disorders","volume":"43","author":"Miller","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib141","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1212\/WNL.43.12.2574","article-title":"Antineuronal antibodies in patients with neurologic complications of primary Sj\u00f8gren's syndrome","volume":"43","author":"Moll","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib142","first-page":"441","article-title":"Hypothyroid myopathy caused by interferon-alpha therapy for chronic hepatitis C","volume":"45","author":"Nagane","year":"2005","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib143","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib144","first-page":"1351","article-title":"Acute axonal polyneuropathy during interferon alpha-2a therapy for chronic hepatitis type C","volume":"17","author":"Negoro","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib145","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia","volume":"74","author":"Nemni","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib146","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2516.2000.00391.x","article-title":"Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders","volume":"6","author":"Ogundipe","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib147","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.077537","article-title":"Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy","volume":"89","author":"Oishi","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib148","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib149","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09546630152607916","article-title":"Acute rhabdomyolysis during treatment of scleromyxedema with interferon alfa","volume":"12","author":"Ozdag","year":"2001","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF02339218","article-title":"Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment","volume":"14","author":"Pacifici","year":"1993","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001622-200311000-00005","article-title":"Interferons: mechanism of action and clinical applications","volume":"15","author":"Parmar","year":"2003","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib152","first-page":"79","article-title":"Severe necrotizing vasculitis in a patient with hepatitis C virus infection treated by interferon","volume":"14","author":"Pateron","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib153","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00415-002-0693-5","article-title":"Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"249","author":"Pavesi","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib154","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajh.2830490432","article-title":"Myasthenia gravis induced by alpha-interferon therapy","volume":"49","author":"P\u00e9rez","year":"1995","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.60.3.348","article-title":"Myasthenia gravis in a patient with chronic active hepatitis C during interferon-\u03b1 treatment","volume":"60","author":"Piccolo","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib156","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","article-title":"Autoimmmunity and thyroid function in patients with chronic active hepatitis treated wit recombinant interferon alpha-2a","volume":"132","author":"Preziati","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib157","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-alpha and autoimmune thyroid disease","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib158","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s004010050740","article-title":"Axonal neuropathy associated with interferon-alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells","volume":"94","author":"Quattrini","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib159","first-page":"1178","article-title":"Myasthenia during interferon alpha therapy","volume":"24","author":"Quilichini","year":"1995","journal-title":"Presse Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib160","first-page":"1592","article-title":"Unilateral ptosis as an initial manifestation of d-penicillamine-induced myasthenia gravis","volume":"20","author":"Raynauld","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib161","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1445-5994.1995.tb00580.x","article-title":"Trigeminal sensory neuropathy induced by interferon-alpha therapy","volume":"25","author":"Read","year":"1995","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib162","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0399-8320(07)78340-9","article-title":"Development of a myasthenic crisis during interferon treatment for chronic C hepatitis","volume":"31","author":"Reffet","year":"2007","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib163","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(97)80091-8","article-title":"Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma","volume":"349","author":"Reinhold","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib164","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/BF01798543","article-title":"Ocular pseudomyasthenic reaction induced by interferon in an AIDS patient","volume":"69","author":"Riedel","year":"1991","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","article-title":"Autoimmunity after alpha interferon therapy for malignant carcinoid tumors","volume":"115","author":"Ronnblom","year":"1991","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib166","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archneur.1997.00550190093020","article-title":"An unusual axonal polyneuropathy induced by low dose interferon alpha 2a","volume":"54","author":"Rutkove","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib167","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.58.5.638","article-title":"Interferon-\u03b1 may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy","volume":"58","author":"Sabatelli","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib168","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1529-8027.2001.01007-47.x","article-title":"Interferon alpha may benefit CIDP patients refractory to standard therapies: description of long-term results on 12 patients","volume":"6","author":"Sabatelli","year":"2001","journal-title":"J. Periph. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib169","first-page":"1041","article-title":"Multiple mononeuropathy during recombinant interferon-alpha 2a therapy for chronic hepatitis C","volume":"32","author":"Sakajiiri","year":"1992","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-510X(95)00134-N","article-title":"Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sj\u00f8gren's syndrome","volume":"132","author":"Satake","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib171","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1526::AID-MUS23>3.0.CO;2-X","article-title":"Treatment of mononeuropathy multiplex in hepatitis C virus and cryoglobulinemia","volume":"21","author":"Scelsa","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib172","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/BF02065527","article-title":"A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulin-emia, and chronic liver disease: effective therapy with interferon-\u03b1","volume":"40","author":"Schirren","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib173","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0248-8663(00)87239-2","article-title":"Polymyositis: a rare complication of interferon alpha therapy","volume":"21","author":"Schleinitz","year":"2002","journal-title":"Rev. Med. Interne."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib174","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/WNL.37.7.1189","article-title":"Interferon treatment of experimental Ross River virus polymiositis","volume":"37","author":"Seay","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib175","first-page":"451","article-title":"Interferon alpha and its contribution to autoimmunity","volume":"7","author":"Selmi","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib176","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","article-title":"Hepatitis C virus-associated extrahepatic manifestations: a review","volume":"19","author":"S\u00e9ne","year":"2004","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib177","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1002\/j.1460-2075.1990.tb07879.x","article-title":"Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses","volume":"9","author":"Shan","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib178","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.4049\/jimmunol.154.11.6203","article-title":"IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis","volume":"154","author":"Shenoy","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib179","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000008097","article-title":"Detection of HVV-specific sequences in chronic myopathy with hepatitis C: improvement with interferon-alpha 2A therapy","volume":"42","author":"Sola","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib180","series-title":"The Cytokine Handbook","first-page":"549","article-title":"Type I interferons","author":"Soos","year":"2003"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib181","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11894-006-0064-y","article-title":"Extrahepatic manifestations of hepatitis C virus","volume":"8","author":"Sterling","year":"2006","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib182","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.4049\/jimmunol.164.12.6593","article-title":"Increased CD40 expression on muscle cells of polymyositis and dermatomyostis: role of CD40\u2013CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production","volume":"164","author":"Sugiura","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib183","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI111243","article-title":"Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons","volume":"73","author":"Sztein","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib184","first-page":"1656","article-title":"Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C","volume":"24","author":"Tambini","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2443.1998.00164.x","article-title":"Type I interferons are essential mediators of apoptotic cell death in virally infected cells","volume":"3","author":"Tanaka","year":"1998","journal-title":"Genes Cells"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib186","first-page":"644","article-title":"Peripheral neuropathy during second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature","volume":"15","author":"T\u00e9llez-Zenteno","year":"2002","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib187","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profile in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib188","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression in DQA1\u204e0501+ children with untreated dermatomyostis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib189","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib190","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.880150805","article-title":"Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IgM monoclonal gammopathy","volume":"15","author":"Thomas","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib191","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","article-title":"New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine","volume":"112","author":"Tilg","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib192","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MEG.0b013e32801106d1","article-title":"Treatment of hepatitis C virus-associated polyneuropathy with pegylated interferon-alpha and ribavirin","volume":"19","author":"Trebst","year":"2007","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib193","first-page":"97","article-title":"Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report","volume":"15","author":"Tunca","year":"2004","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib194","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0002-9378(95)90402-6","article-title":"Interferons: biochemistry and mechanisms of action","volume":"172","author":"Tyring","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib195","first-page":"155","article-title":"Treatment with interferon-alpha 2a in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"40","author":"Ueda","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib196","first-page":"324","article-title":"Development of cryoglobulinemia and polyneuropathy in a chronic myeloid leukemia patient during interferon-alpha treatment","volume":"40","author":"Uoshima","year":"1999","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib197","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI115543","article-title":"Interferon-\u03b1 restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells","volume":"88","author":"Upadhyaya","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib198","first-page":"221","article-title":"Exacerbation of myasthenia gravis during interferon-\u03b1 treatment","volume":"144","author":"Uyama","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib199","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00002281-200311000-00003","article-title":"Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge","volume":"15","author":"Uzel","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib200","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1200\/JCO.2001.19.17.3794","article-title":"Rhabdomyolysis, when observed with high-dose interferon-alfa (HDI) therapy, does not always exclude resumption of HDI","volume":"19","author":"Van Londen","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib201","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2005.06.010","article-title":"Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b","volume":"37","author":"Venezia","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib202","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type 1 interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib203","first-page":"609","article-title":"Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection","volume":"4","author":"Warabi","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib204","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s005350170038","article-title":"Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin","volume":"6","author":"Weegink","year":"2001","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/art.1780380324","article-title":"Polymyositis, pulmonary fibrosis, and hepatitis C","volume":"3","author":"Weidensaul","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib206","first-page":"251","article-title":"The interferon genes","volume":"33","author":"Weissman","year":"1986","journal-title":"Proc. Nucl. Acid Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib207","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.2004.049502","article-title":"Interferon alfa treatment for Sj\u00f8gren's syndrome associated neuropathy","volume":"76","author":"Yamada","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.12.008_bib208","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/107999000750053799","article-title":"Cytochrome c release, mitochondrial membrane depolarization, capase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells","volume":"20","author":"Yanase","year":"2000","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib209","first-page":"61","article-title":"Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha","volume":"112","author":"You","year":"1999","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00063-006-1030-z","article-title":"Therapy with peginterferon alfa in a patient with polyneuropathy caused by hepatitis-associated vasculitis","volume":"15","author":"Zoras","year":"2006","journal-title":"Med. Klin."},{"key":"10.1016\/j.jneuroim.2008.12.008_bib211","first-page":"2488","article-title":"Peripheral neuropathy during interferon-alpha therapy in patients with cryoglobulinemia and hepatitis virus infection","volume":"24","author":"Zuber","year":"1997","journal-title":"J. Rheumatol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808004979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808004979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:02Z","timestamp":1759047062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808004979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":211,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0165572808004979"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.008","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon alpha and neuromuscular disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}